ADVB - CIK 0001941029
The table below shows Advanced Biomed Inc.'s cash flow statement line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Operating cash flow | -$5.83M | -$2.13M |
| Capital expenditure | $31.65K | $74.11K |
| Investing cash flow | -$31.65K | -$74.11K |
| Dividends paid | - | - |
| Stock buybacks | - | - |
| Financing cash flow | $5.93M | $1.87M |
Advanced Biomed Inc. reported operating cash flow of -$5.83M for fiscal year 2025. That is down 173.9% from -$2.13M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.